Best Pharma Manufacturing Podcasts (2024)

1
FDA approves BMS schizophrenia drug, bluebird bio announces layoffs, J&J talc subsidiary files for bankruptcy [The good, the bad, the ugly] 3:37

5d ago3:37

3:37

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good —FDA approves BMS schizophrenia drug The bad — bluebird bio announces layoffs The ugly —J&J talc subsidiary files for bankruptcyBy Pharma Manufacturing

1
"Matter": why Steerworld is a made-in-India manufacturing success in construction, pharma & food 1:01:46

20d ago1:01:46

1:01:46

In this episode we host Dr Babu Padmanabhan, who is a first generation entrepreneur who went from being a scientist to becoming a businessman. He has built a sizeable organisation around manufacturing machines and digitising manufacturing for three industries. Steerworld is a bonafide made-in-India success story with plants all over the world. Babu…

1
Alpha-Synuclein Testing Comes of Age 29:24

18h ago29:24

29:24

In the latest episode of the In Vivo podcast, Russ Lebovitz, the co-founder and scientist behind Amprion, a diagnostics company, discusses the role of alpha-synuclein misfolding in neurodegenerative diseases and how early alpha-synuclein detection has the potential to mitigate the impacts of diseases ranging from Parkinson's disease to Lewy body de…

1
Breaking down BIOSECURE—Industry implications and what comes next 20:02

20h ago20:02

20:02

Since the introduction of the BIOSECURE Act in January, named companies and U.S.-based biopharmas alike have speculated on what the legislation could mean for the life sciences industry. In this week's episode of "The Top Line," Fierce Pharma staff writer Fraiser Kansteiner sits down with Arnold & Porter’s Life Sciences practice chair Dan Kracov to…

1
Q&A Session: PIK3CA Mutations and Breast Cancer 19:02

1d ago19:02

19:02

Join us for an informative discussion about PIK3CA testing and treatment with Dr. Neil IyengarBy Citeline

1
Democratically enabled "Reviews" guide you to the right software: the story of G2 & Godard Abel 42:51

2d ago42:51

42:51

In this episode of theUpStreamLife.com we talk Godard Abel, the CEO and co-founder of G2 who talks about why the G2.com platform is far better, and trusted, than Gartner in guiding people towards buying software. Gartner serves Fortune500 CIOs/CTOs, but what about an entire universe of business; this is where G2 enables small companies and SMBs, or…

1
Conference Catch-Up: LSX World Congress USA 2024 13:47

3d ago13:47

13:47

Discover the game-changing insights from the LSX World Congress USA!Join Janelle Hart, Managing Editor at Citeline, a Norstella Company, as she explores the key takeaways from the LSX World Congress USA meeting. In this episode, Janelle sits down with Tony Shi, Principal and Head of Digital Health and Access Innovation Strategy, and Eric Boyda, Con…

1
The tech that powers travel: how Sabre's engineering enables startups, OTAs, airlines & travellers 58:11

3d ago58:11

58:11

In this episode of theUpStreamLife.com, we speak with Sabre India's managing director Sriram Gopalswamy. Sriram talks about the evolution of the travel industry from mainframes to Saas; powering online travel agents, and customer experiences. 00:00 - Introduction 02:00 - Sriram talks about what happens at Sabre worldwide. 11:15 - Creating a seamles…

1
The Promise of Epigenetic Therapeutics in Alcohol-Associated Hepatitis ft. DURECT President and CEO Dr. James Brown 32:33

3d ago32:33

32:33

In this episode, Ayesha spoke with James E. Brown, DVM, co-founder, President and CEO of DURECT. DURECT is pioneering a therapeutic strategy by leveraging the potential of epigenetic modulation to alter the trajectory of severe and life-threatening conditions like acute organ injury and cancer. The company is specifically focused on the development…

1
156 - Combination Product Governance, Big Pharma to Medical Device Startups, Risk Management, Scale Up Challenges, Drug Delivery Innovations, and Home Administration with Laxman Halleppanavar 33:01

3d ago33:01

33:01

On this episode, I was joined by Laxman Halleppanavar, Head of Portfolio Strategy and Management at Credence MedSystems, Inc. On this episode, Laxman, highlights the differences in regulatory oversight and risk management between medical devices and pharmaceuticals, the trend towards home administration of drugs, sustainability goals, and the chall…

1
The Future Of Drug R&D Is Self-Driving 30:18

5d ago30:18

30:18

In the latest episode of the In Vivo podcast, Alan Aspuru-Guzik, a pioneer in chemical engineering who holds many positions, talks about how he is folding in robotic automation, generative AI and quantum computing in his self-driving lab.By Citeline

1
Weird Ford Patent; Amphibious Car Demand; Tool & Die Strike | Today in Manufacturing Ep. 189 1:19:34

5d ago1:19:34

1:19:34

The Today in Manufacturing Podcast is brought to you by the editors of Manufacturing.net and Industrial Equipment News (IEN). This week's episode is brought to you by Sikich. Download 7 Key Areas for Modernizing Distribution to unlock seven key areas of supply chain management that enterprises can leverage to retain their market share and stay ahea…

1
Drug Fix: Pfizer Pulls Sickle Cell Drug, ODAC Calls Back Approved Products, New AAM CEO 37:39

8d ago37:39

37:39

Pink Sheet reporters and editors discuss Pfizer’s abrupt decision to withdraw Oxbryta (:32), the US FDA’s Oncologic Drugs Advisory Committee bringing sponsors of approved products back to discuss labeling changes while competitors are pending (10:46), and the new CEO of a generic industry trade association (27:34).More On These Topics From The Pink…

1
ESMO, WCLC lung cancer data spark hope—and debate 23:17

8d ago23:17

23:17

At the recent World Conference on Lung Cancer and European Society for Medical Oncology annual meetings, two packages of lung cancer data from a partnership between Akeso and Summit Therapeutics and another collaboration between iTeos Therapeutics and GSK showed much promise of disrupting the current standard of care. But they also drew some questi…

1
[Extended Release] Schizophrenia treatment barriers, KarXT, and the future of neuroscience 17:28

9d ago17:28

17:28

Join senior editor Andrea Corona and Sam Clark, CEO and founder of Terran Biosciences, for a discussion on KarXT's landmark approval, schizophrenia treatment barriers, prodrugs, and more. Extended Release is an Off Script series that allows us to revisit conversations with our sources to explore new developments, gain deeper insights, and provide u…

1
155 - FDA Compliance Programs, Program 7536.000: CDER vs. CDRH led Inspections, Mock PAI's, Supplier Management, and What is a Manufacturer? with Laurie Auerbach 25:25

10d ago25:25

25:25

On this episode, I was joined by Laurie Auerbach, President and Principal Consultant, Compliance Prodigies, LLC. In this episode, Laurie dives into the complexities of FDA compliance programs, specifically focusing on combination product inspections and the 7356.000 Inspections of CDER-led or CDRH-led Combination Products compliance program. Laurie…

1
Pioneering mRNA Therapies for Lung Diseases 34:15

10d ago34:15

34:15

In this episode, Vera spoke with Carsten Rudolph, PhD, CEO of Ethris. Ethris was founded by Dr. Rudolph and Professor Christian Plank with the goal of establishing messenger RNA (mRNA) as a novel drug modality for lung diseases such as asthma and rare pulmonary conditions like primary ciliary dyskinesia (PCD) and pulmonary alveolar proteinosis. Eth…

1
Challenges in the Development and Manufacturing of ADCs 16:24

11d ago16:24

16:24

In this podcast, Andrew Warmington, Manufacturing Editor, Citeline, joins together with industry experts, Simone Secchi, R&D Process Chemist, Olon Group, and Matthieu Culie, Head of Development and GMP Manufacturing, GTP Bioways, Olon Group, to discuss the challenges in the development and manufacturing of ADCs.…

1
Novo Nordisk shares phase 2a obesity trial data, Achilles Therapeutics ends TIL-based therapy, Express Scripts sues FTC [The good, the bad, the ugly] 3:24

12d ago3:24

3:24

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Novo Nordisk shares phase 2a trial data for obesity treatment The bad — Achilles Therapeutics to discontinue TIL-based therapy The ugly — Express Scripts files lawsuit against FTC…

1
Fastest & Slowest Selling Cars; Screw Solves Mystery; Tesla Semi Fire | Today in Manufacturing Ep. 188 1:29:23

12d ago1:29:23

1:29:23

The Today in Manufacturing Podcast is brought to you by the editors of Manufacturing.net and Industrial Equipment News (IEN). This week's episode is brought to you by QAD Redzone. A big part of maintaining a functional and efficient manufacturing environment is to understand what it takes to make a team work. And for a business like NUCO, who has b…

1
Light Box and its bets on the India story: consumption, supply chains & an evolving customer 1:01:46

12d ago1:01:46

1:01:46

In this episode we bring you Sandeep Murthy of Light Box. The venture fund has only invested in a dozen plus Indian startups and has been a partner to several startups by enabling their operations to scale. Sandeep talks about the growth of the India story and beyond in this podcast. 00:00 - Introduction to Light Box and the Indian venture opportun…

1
Recapping Digital Pharma East 2024 8:23

15d ago8:23

8:23

In this week's episode of "The Top Line," we’re recapping and discussing the major trends from Digitial Pharma East, which took place in Philadelphia last week. The event brought together marketing experts from across the life sciences industry. Fierce Pharma Marketing's Andrea Park and Ben Adams talk about major trends from the event that came up …

1
An investor, a CA & a journalist discuss markets, economy, transparency and transformation in India 1:00:57

15d ago1:00:57

1:00:57

How should corporations & aspiring youth look at Indian markets and its political economy. Look no further than this podcast with Pavan Sharma, partner at BCL India, Saketh R, founder of QuickAlpha and senior journalist Vishal Krishna. 00:00 - Introduction to the guests, setting the context of discussing India’s economic future & aspirations of you…

1
September 2024 Datamonitor Healthcare Podcast: Radiopharmaceutical Usage is Heating Up 29:56

16d ago29:56

29:56

Emma Wille chats with oncology team director Dana Gheorghe, PhD, about the resurgence of radiopharmaceutical therapies in oncology.Other platforms (in addition to SoundCloud):Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZ…

1
[Solutions Spotlight] Optimizing contamination control in pharma facilities 12:32

16d ago12:32

12:32

Drugmakers face stringent regulations to ensure that products remain free from contaminants that could compromise safety and efficacy. Effective contamination control requires meticulous monitoring of environmental conditions, rigorous testing of products, and implementation of robust cleaning and sterilization procedures. To better understand thes…

1
154 - IVD's, LDT's, Companion Diagnostics, Precision Medicine, Clinical Validation, Biomarkers, Test Methods, Detection Limits and CLIA with Devon C. Campbell 37:31

17d ago37:31

37:31

On this episode, I was joined by Devon Campbell, Founder and Managing Director of Prodct. Devon covers the differences between IVDs, companion diagnostics, and precision medicine, the risk management aspects specific to IVDs, and the design, verification, and validation processes involved. Devin shares his extensive experience in both big pharma en…

1
Silencing Disease: Shifting Treatment Paradigms with RNAi Therapeutics ft. Alnylam’s VP Research Dr. Kirk Brown 30:15

17d ago30:15

30:15

In this episode, Ayesha spoke with Kirk Brown, PhD, Vice President of Research at Alnylam Pharmaceuticals. Alnylam is focused on developing RNAi medicines to transform the way diseases like cardiovascular and neurological diseases are treated. Dr. Brown’s preclinical work combining stable siRNA designs with alternative conjugation strategies has en…

1
Roche wins FDA approval for subcutaneous cancer immunotherapy, Moderna to cut $1.1B in R&D expenses, Teva settles $80M opioid case with Baltimore [The good, the bad, the ugly] 3:34

19d ago3:34

3:34

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Roche snags FDA nod for subcutaneous cancer immunotherapy The bad — Moderna to cut R&D expenses by $1.1B The ugly — Teva reaches $80M opioid settlement with Baltimore…

1
Kawasaki Raided; Old Pipe Maker Closing; Button Reinvented | Today in Manufacturing Ep. 187 53:32

19d ago53:32

53:32

The Today in Manufacturing Podcast is brought to you by the editors of Manufacturing.net and Industrial Equipment News (IEN). This week's episode is brought to you by QAD Redzone. Every week, we cover the five biggest stories in manufacturing, and the implications they have on the industry moving forward. This week: - Kawasaki Heavy Plant Raided fo…

1
Health-Related Quality of Life Considerations In Clinical Trials 16:44

20d ago16:44

16:44

In this podcast, Janelle Hart, Managing Editor at Citeline, teams up with industry experts Mai Yee Mishir, Senior Director of Global Regulatory Affairs, and Sally-Ann McDowell, Senior Director of Clinical Development Strategy at Advanced Clinical, to discuss the vital role of HRQoL in clinical trials. Listen now.…

1
Over the Counter: Data Tech CEO On Digital Tools Driving Faster, More Sustainable Personal Care 36:37

22d ago36:37

36:37

In this episode, HBW chats with Neil D’Souza, CEO of Makersite GmbH, a Stuttgart, Germany-based data software company that offers product data management tools that enable personal care firms to manage product sustainability, cost and compliance. D’Souza provides his take on what defines sustainable product development and how companies can use tec…

1
Drug Fix: US FDA Worries About Celebs Endorsing Drugs, Post-Chevron Lawsuits Emerging 24:28

22d ago24:28

24:28

Introduction: Pink Sheet reporter and editor discuss the FDA’s latest advertising enforcement letter, which targeted a migraine treatment TV commercial featuring Serena Williams, and its impact on drug promotion (:36), as well as the now growing list of legal cases targeting agency decisions with Chevron deference overturned (13:32).More On These T…

1
A closer look at the Fierce 50 7:24

22d ago7:24

7:24

In this week's episode of "The Top Line," we will dive into the annual Fierce 50 special report. We share the stories of a select few 2024 Fierce 50 honorees and interesting highlights from this year's special report. To learn more about the topics in this episode: Fierce 50 of 2024 Innovation Honorees Health Equity Honorees Social Impact Honorees …

1
September 2024 Datamonitor Healthcare Podcast: Diving into the TME 22:30

22d ago22:30

22:30

Emma and Summer meet with oncology analyst Flora to discuss the therapeutic potential of exploring the tumor microenvironment.Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU…

1
The Generics Bulletin Podcast: Recent And Upcoming Industry Events 17:14

23d ago17:14

17:14

Generics Bulletin's editorial team discusses recent conferences held by Medicines for Europe and the AAM, while looking ahead to the key off-patent industry events on the calendar over the next few months and beyond.By Citeline

1
153 - USP 382, Elastomeric Component Functional Suitability, Delivery Systems, Spikes, IV Bags and Alternate Packaging with Fran Degrazio 21:56

24d ago21:56

21:56

On this episode, I was joined by Fran Degrazio, President & Principal Consultant at Strategic Parenteral Solutions and Executive Editor at Drug Delivery Leader. On this episode, Fran explores the transition from USP 381 to 382, focusing on stoppers and elastomeric closures. Fran explains the importance of evaluating packaging components as a system…

1
【3分で解説世界のファーマ】第21回中国企業日本で続々治験開始へ (Japanese-language podcast) 3:23

27d ago3:23

3:23

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「Multiple Chinese Firms Expand Global Phase III Trials To Japan（邦訳：中国企業、第三相グローバル治験の地域を続々と日本に拡大）」 https://scrip.citeline.com/SC150842/Multiple-Chinese-Firms-Expand-Global-Phase-III-Trials-To-JapanPlaylist: https://soundcloud.com/citeli…

1
J&J, '차별화된' 비만 자산에 관심있어 (Korean-language podcast) 3:16

26d ago3:16

3:16

호아킨 두아토 존슨앤존슨 대표가 모건스탠리 헬스케어 컨퍼런스에서 발표한 내용입니다.https://scrip.citeline.com/SC150846/JJ-Interested-In-Differentiated-Obesity-AssetsPlaylist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniBy Citeline

1
Pfizer, Valneva share phase 2 Lyme vax data, IN8bio axes workforce, AstraZeneca employees detained in China [The good, the bad, the ugly] 4:12

26d ago4:12

4:12

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Pfizer, Valneva share phase 2 positive Lyme vax data The bad — IN8bio axes workforce, halts trial The ugly — AstraZeneca employees detained in ChinaBy Pharma Manufacturing

1
Deli Meat Outbreak, Military Helicopter Crash, VW's No Lay-Offs Pledge | Today in Manufacturing Ep. 186 1:26:02

26d ago1:26:02

1:26:02

The Today in Manufacturing Podcast is brought to you by the editors of Manufacturing.net and Industrial Equipment News (IEN). This week's episode is brought to you by MSI Data. Many field service organizations understand the technology they use in their day-to-day service operations, but don’t take the necessary steps to tap into its full potential…

1
Scrip's Five Must-Know Things - 9 September 2024 14:56

26d ago14:56

14:56

Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 September 2024. In this episode: J&J interested in differentiated obesity assets; Kerendia hits in heart failure; strong HERCULES data keep Sanofi’s MS plans alive; WCLC preview; and Mankind sets eyes on 5x growth.https://scrip.citeline.com/SC150865/Quick…

1
Drug Fix: Pediatric Rare Disease PRV Deadline Approaches, Potential Makena Compounding Ban 34:19

29d ago34:19

34:19

Pink Sheet reporter and editors discuss the potential fallout if the US FDA’s rare pediatric disease priority review voucher program is allowed to sunset on 1 October (:30), as well as an upcoming agency advisory committee meeting on potentially banning compounding of the now withdrawn pre-term birth prevention drug Makena (18:39).More On These Top…

1
A look at flu vaccine manufacturing and supply in the post-pandemic era 17:10

29d ago17:10

17:10

In this week's episode of "The Top Line," we’re looking at what goes into manufacturing and supply of flu vaccines. Fierce Pharma’s Zoey Becker chats with Stefan Merlo, vice president of commercial operations, North America at CSL Seqirus. He discusses the company's differentiated flu vaccine portfolio and how its manufacturing process has evolved …

1
Pharma Matters Podcast: Contract Pharma Talks with Rick Knight of Pfizer CentreOne 17:04

30d ago17:04

17:04

Global Head of Strategic Account Management for Pfizer CentreOne talks with host Ben Locwin about the advantages of working with an integrated CDMO.By Contract Pharma

1
152 - Global Medical Device Podcast Interview: Behind the Combinate Podcast, Combination Products Why, Unique Episodes, Pyramids and Books with Etienne Nichols & Subhi Saadeh 40:48

1M ago40:48

40:48

This episode is a cross-post of an interview I did with Etienne Nichols over at the Global Medical Device Podcast at GreenLight Guru(Episode #380). In this episode, Etienne and I discuss: 02:50 The Start of the Combinate Podcast 06:00 Efficiency and Tools in Podcast Production 08:40 Understanding Combination Products 09:43 Regulatory Frameworks and…

1
The Science of Sleep: Unmet Needs and Treatments for Narcolepsy ft. Avadel Pharma’s Dr. Jennifer Gudeman 33:38

1M ago33:38

33:38

In this episode, Ayesha spoke with Jennifer Gudeman, Pharm D, Senior Vice President, Medical and Clinical Affairs, Avadel Pharmaceuticals plc, a biopharmaceutical company working on innovative solutions to the development of medications that disrupt treatment paradigms and address unmet needs. The company is currently focused on developing treatmen…

1
FDA approves Illumina cancer biomarker test, BioMarin reveals more layoffs, FDA hits API maker Global Calcium with 483 [The good, the bad, the ugly] 3:30

1M ago3:30

3:30

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Illumina cancer biomarker test The bad — BioMarin reveals more layoffs The ugly — FDA hits API maker Global Calcium with 483By Pharma Manufacturing

1
Angry Boeing Workers; Union Corruption; Pharma Explosion | Today in Manufacturing Ep. 185 1:24:13

1M ago1:24:13

1:24:13

The Today in Manufacturing Podcast is brought to you by the editors of Manufacturing.net and Industrial Equipment News (IEN). This week's episode is brought to you by MSI Data. Download "Your Guide to Field Service Maturity" now to learn what “field service maturity” is, why it matters and how to get started. Every week, we cover the five biggest s…

1
Scrip's Five Must-Know Things - 2 September 2024 14:53

1M ago14:53

14:53

Audio roundup of selected biopharma industry content from Scrip over the business week ended 30 August 2024. In this episode: summer ADC dealmaking continues apace; a look at cell therapies in Japan; Pfizer’s new US digital consumer platform; Galapagos’s US point of care CAR-T study; and Novartis partners with Lindy on biologics delivery.https://sc…

1
Drug Fix: New US FDA Developments In AI Regulation 16:59

1M ago16:59

16:59

Pink Sheet reporter and editors discuss new developments in the FDA’s plans to regulate artificial intelligence and drugs associated with it, including a new AI Council within CDER, as well as some of the unanswered questions about AI in drug development.More On These Topics From The Pink Sheet Artificial Intelligence: CDER’s New Council Takes Char…

Podcasts Worth a Listen

Pharma Manufacturing Podcasts

Podcasts Worth a Listen

Quick Reference Guide